Pharsight

1. List of Acetaminophen drug patents

Application	Filing Date	Opposition Party	Legal Status
EP10714862A	2013-12-19	Wibbelmann, Jobst	Opposition rejected

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8741959	FRESENIUS KABI USA	Paracetamol for parenteral administration	Apr, 2030 (6 years from now)

Do you want to check out ACETAMINOPHEN patents from before 2022?

Market Authorisation Date: 28 October, 2015

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

Strength	Dosage	Availability
1GM/100ML (10MG/ML)	SOLUTION;INTRAVENOUS	Prescription

ACETAMINOPHEN family patents

European Union

United States

Denmark

Spain

Poland

Brazil

China

Australia

Hungary

Portugal

Japan

Hong Kong

2. List of Ofirmev drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9987238	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	Nov, 2028 (5 years from now)
US10383834	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	Nov, 2028 (5 years from now)
US9610265	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	Nov, 2028 (5 years from now)
US9610265 (Pediatric)	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	May, 2029 (5 years from now)
US9987238 (Pediatric)	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	May, 2029 (5 years from now)
US9399012	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	Sep, 2031 (8 years from now)
US9399012 (Pediatric)	MALLINCKRODT HOSP	Reduced dose intravenous acetaminophen	Mar, 2032 (8 years from now)

Do you want to check out OFIRMEV patents from before 2022?

Market Authorisation Date: 02 November, 2010

Treatment: Modified dosing regimen for the management of mild to moderate pain or management of moderate to severe pain as an adjunct to opioid analgesics; Modified dosing regimen for the reduction of fever; Mod...

Dosage: SOLUTION;INTRAVENOUS